PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of oamjmsMacedonian Journal of Medical SciencesOpen Access Macedonian Journal of Medical SciencesArchivesSubmissionsAuthorsId DesignId Press
 
Open Access Maced J Med Sci. 2017 July 25; 5(4): 497–500.
Published online 2017 July 24. doi:  10.3889/oamjms.2017.141
PMCID: PMC5535668

Pigmented Paraaxillary Located “Complex” Basal Cell Carcinoma Imitating clinically irritated Melanocytic Lesion - Succesfull Surgical Approach in Bulgarian Patient

Abstract

BACKGROUND

Basal cell carcinoma (BCC) is the most frequently encountered neoplasm worldwide. While nodular BCC is the most frequent clinical subtype, other forms of BCC, such as superficial, cystic, morpheiform, infiltrative, and pigmented may also be encountered.

CASE PRESENTATION

We present the case of a 67-year-old male with a relatively well-defined infiltrative, pigmented plaque with multiple colours and peripheral growth situated in the right axillary region. The histopathologic examination performed after complete surgical excision of the tumour revealed a complex pigmented BCC with macronodular, fibroepithelioma-like, cystic, focally infiltrative and basosquamous features.

CONCLUSION

Uncommon locations of BCCs in sun-protected areas such as the axillary region require a higher degree of suspicion for diagnosis. The complex histology of the presented case, including subtypes with differing biologic attributes, emphasises the importance of histopathological examination in the diagnosis and therapeutic management of BCC.

Keywords: basal cell carcinoma, axillary region, basosquamous carcinoma

Introduction

Basal cell carcinoma (BCC) is the most frequently encountered cutaneous neoplasm worldwide, accounting for approximately 90% of all skin cancers [1], with an incidence of 2,000 cases /100,000 population [2]. Most BCCs develop in individuals with Fitzpatrick photo-types I or II and arise in sun-exposed areas, mostly in the head and neck and less frequently in the trunk and limbs [3, 4]. Less than 4% of all BCCs occur in the genital and perianal region [5]. It is a slow growing tumour with a 0.5% metastatic rate [6], but with a considerable risk of local invasion and destruction if left untreated.

Several risk factors have been described in the pathogenesis of BCC. Long-term exposure to sunlight or artificial ultraviolet light (UV), especially UVB [7], represents the main BCC- inducing factor. Phenotypic and genetic traits (e.g. inherited diseases or syndromes such as basal cell nevus syndrome (Gorlin-Goltz syndrome), xeroderma pigmentosum, epidermodysplasia verruciformis, albinism, and Gardner’s syndrome); a familial history of skin cancer; DNA repair deficiencies leading to chromosomal instability; immunosuppression; exposure to other environmental carcinogenic factors (e.g. arsenic, alkylating agents, polycyclic aromatic hydrocarbons) [8]; accidental or therapeutic exposure to ionizing radiation; and repeated cutaneous trauma have also been designated as important factors in the development of BCCs [3, 9, 10, 11].

A constitutive activation of the sonic hedgehog signalling pathway caused by acquired mutations in the PTCH and SMO genes [11], localised in the basal epidermal cell layer represents the early developmental determinant of BCCs, while other molecular alterations of P53 and melanocortin-1 receptor genes also play essential pathogenic roles [13, 14].

Nodular BCC is considered the most frequent clinical subtype, while other forms (superficial, cystic, morpheaform, infiltrative, pigmented tumours, and others) account for less than 10% of all BCCs [15].

Fibroepithelioma of Pinkus is another distinct BCC subtype, mostly found in the trunk; it can resemble an acrochordon, compound melanocytic nevus, melanoma, seborrheic keratosis, or other benign skin lesions [16].

The clinical diversity of BCCs emphasises the importance of histopathological examination in the diagnosis and therapeutic management of BCC. While nodular BCCs have definite clinical and histopathologic features, the other variants (adenoid, cystic, morpheaform, pigmented and others) may show more complex features and less predictable outcomes.

The differential diagnosis can be challenging; the major risk is that of mistaking BCC for benign, harmless lesions [17] or, on the other hand, for more severe, life threatening malignancies such as melanoma.

Standard surgical excision or Mohs micrographic surgery remain the mainstays of localised BCC treatment. In particular situations of inoperable cases, as in patients with locally advanced, metastatic disease or those with severe comorbidities or immunosuppression, BCCs may be approached with more conservative, nonsurgical methods [18].

The following report depicts an unusual case of BCC in a Bulgarian patient with a pigmented skin lesion localised in the axillary region. Histopathologic examination performed after complete surgical excision revealed the diagnosis of a complex pigmented BCC with macronodular, fibroepithelioma-like, cystic, focally infiltrative, and basosquamous features.

Case report

We report the case of a 67-year-old male who presented to the dermatology department with a skin lesion in the right axillary region that had been gradually growing for the past ten years (Fig. 1a). The lesion had bled two days before presentation but was otherwise asymptomatic. The patient did not report any food, or drug allergies or intolerances and his medical history were unremarkable except for benign prostatic hyperplasia. Clinical examination revealed a relatively well defined, infiltrated plaque with an uneven eroded surface, irregular borders, variegated colours, and peripheral growth in the right axillary region, measuring approximately 1x1.5 cm in greatest diameter (Fig. 1b).

Figure 1
1a) Clinical appearance of the lesion in the right axillary region; 1b) Preoperative markings showing wide excision margins; 1c) Surgical defect after excision of the lesion; 1d) Further excisional debridement of the subcutaneous fat to ensure complete ...

The differential diagnosis included pigmented BCC, irritated melanocytic nevus, pigmented seborrheic keratosis, benign or malignant adnexal tumours, and melanoma. Paraclinical tests were unremarkable as well, with sinus tachycardia on ECG, normal abdominal ultrasound, and a chest x-ray showing no visible infiltrations of the lung parenchyma, free costodiaphragmatic recess, and an extended aortic arch. Taking into consideration the history of change and the concern for a possibly aggressive malignant process, the lesion was surgically excised in an elliptical manner with wide margins under local anaesthesia with 2% lidocaine and epinephrine. Primary closure of the defect was achieved (Fig. 1c--f)f) followed by application of antiseptic ointment dressings. Postsurgical health status was eventless, and the patient was discharged with follow-up instructions. Histological examination revealed a large, complex basal cell carcinoma with several different histopathologic types, including macronodular, fibroepithelioma-like, cystic, focally infiltrative, and basosquamous (Fig. 2 a--hh).

Figure 2
2a and 2b) These are slightly different views of the same area of the tumour. There are epidermal atrophy and keratin debris above the stratum corneum. The hyalinized papillary dermal material likely represents secondary amyloid formation. The narrow ...

Many of these types (fibroepithelioma-like, cystic, basosquamous) are indicative of follicular/primary epithelial germ differentiation, while the infiltrative and basosquamous carcinoma areas are associated with more biologically aggressive tumours. The probable amyloid formation seen in Figures Figures2a2a and and2b2b is known to occur in basal cell carcinoma, and derives from degenerated basaloid cells, with modification of keratin filaments into a beta-pleated sheet configuration.

Discussion

Basal cell carcinoma is the most frequent type of skin cancer, and a strong association between its development and long-term sun exposure has been established [19].

However, its development in uncommon locations - such as sun-protected areas - requires a higher degree of suspicion for diagnosis. There exist few reports of axillary BCC cases, with an estimated a prevalence of 0.17%. As of August 2014, there were only 81 cases of axillary BCCs presented in scholarly journals [20]. Cohen observed that these tumours occurred predominantly in Caucasians, without significant BCC-associated risk factors [21]. The histologic sub-types associated with this localisation were mainly superficial or nodular, with an excellent prognosis after complete surgical removal [21]. No case of metastatic spread has been reported. However, the development of axillary tumours in patients with Gorlin-Goltz syndrome emphasises the risk of their inheritance, an important pathogenetic factor that should be thoroughly investigated. Moreover, the report of a linear adamantanoid BCC in the axilla, a sub-type with an increased risk of local invasion and recurrence [22], suggests the need for caution in the diagnosis and management of tumours localised in sun-protected areas.

Because of the wide-ranging clinical differential diagnosis in the presented case, including an array of benign and malignant tumours, histologic evaluation was carried out to determine the correct diagnosis. The peculiarity of our case consisted of its mixed histopathological patterns of macronodular, fibroepithelioma-like, cystic, focally infiltrative, and basosquamous features that have rarely been described in axillary BCCs. Infiltrative and basosquamous carcinomas are considered aggressive tumours, with an increased risk of recurrence and metastases. The treatment approach should focus on surgical excision with free margins to prevent tumour recurrence.

Although the tumour had slowly progressed over the previous ten years, the reason the patient presented for a dermatologic appointment was the acute symptom of bleeding. This reinforces the importance of educational campaigns and dermoscopic screenings for early diagnosis and treatment of skin cancers.

While international reports suggest a worldwide increase in the incidence of non-melanoma skin cancers [23], generally attributed to ultraviolet exposure, it would be useful to study the epidemiology of BCCs that develop in sun-protected areas, to gain more insight into the pathogenesis of this subset of tumours.

In conclusion, uncommon locations of BCCs in sun-protected areas such as the axillary region require a higher degree of suspicion for diagnosis. The complexity of histopathologic subtypes in the presented case, each with potentially different biologic attributes, emphasises the importance of histopathological examination in the diagnosis and therapeutic management of BCC.

Footnotes

Funding: This research did not receive any financial support.

Competing Interests: The authors have declared that no competing interests exist.

References

1. Urbach F. Incidence of non melanoma skin cancer. Dermatol Clin. 1991;9:751–5. PMid:1934649. [PubMed]
2. Dourmishev A, Popova L, Dourmishev L. Basal-cell carcinoma and squamous-cell carcinomas:Epidemiology, location and radiotherapy. Skin Cancer. 1996;11:195–200.
3. Chung S. Basal Cell Carcinoma. Arch Plast Surg. 2012;39(2):166–170. https://doi.org/10.5999/aps.2012.39.2.166 PMid:22783519 PMCid:PMC3385325. [PMC free article] [PubMed]
4. Dourmishev LA, Rusinova D, Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J. 2013;4(1):12–17. https://doi.org/10.4103/2229-5178.105456 PMid:23439912 PMCid:PMC3573444. [PMC free article] [PubMed]
5. Mulvany NJ, Allen DG. Differentiated intraepithelial neoplasia of the vulva. Int J Gynecol Pathol. 2008;27:125–35. https://doi.org/10.1097/pgp.0b0318134ea34 PMid:18156987. [PubMed]
6. Lo JS, Snow SN, Reizner GT, Mohs FE, Larson PO, Hruza GJ. Metastatic basal cell carcinoma:Report of twelve cases with a review of the literature. J Am Acad Dermatol. 1991;24:715–9. https://doi.org/10.1016/0190-9622(91)70108-E. [PubMed]
7. Dessinioti C, Antoniou C, Katsambas A, Stratigos AJ. Basal cell carcinoma:What’s new under the sun. Photochem Photobiol. 2010;86:481–91. https://doi.org/10.1111/j.1751-1097.2010.00735.x PMid:20550646. [PubMed]
8. Cabrera HN, Gómez ML. Skin cancer induced by arsenic in the water. J Cutan Med Surg. 2003;7:106–11. https://doi.org/10.1177/120347540300700202 PMid:12447618. [PubMed]
9. Chan PC, Haseman JK, Boorman GA, Huff J, Manus AG, Cardy RH. Forestomach lesions in rats and mice administered 3-chloro-2-methylpropene by gavage for two years. Cancer Res. 1986;46:6349–52. PMid:3779651. [PubMed]
10. Kubasiewicz M, Starzy-ski Z. Case-referent study on skin cancer and its relation to occupational exposure to polycyclic aromatic hydrocarbons. I. Study design. Pol J Occup Med. 1989;2:221–8. PMid:2489425. [PubMed]
11. Emmert S, Schön MP, Haenssle HA. Molecular biology of basal and squamous cell carcinomas. Adv Exp Med Biol. 2014;810:234–52. https://doi.org/10.1007/978-1-4939-0437-2_13. [PubMed]
12. de Zwaan SE, Haass NK. Genetics of basal cell carcinoma. Australas J Dermatol. 2010;51:81–92. https://doi.org/10.1111/j.1440-0960.2009.00579.x PMid:20546211. [PubMed]
13. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009;361:1164–1172. https://doi.org/10.1056/NEJMoa0905360 PMid:19726763. [PubMed]
14. Saxena K, Manohar V, Bhakhar V, Bahl S. Adenoid basal cell carcinoma:a rare facet of basal cell carcinoma. BMJ Case Rep. 2016;2016:10. [PubMed]
15. Viera M, Amini S, Huo R, Oliviero M, Bassalo S. A New Look at Fibroepithelioma of Pinkus. Features on Confocal Microscopy. J Clin Aesthet Dermatol. 2008;1(2):42–44. PMid:21103323 PMCid:PMC2989825. [PMC free article] [PubMed]
16. Aydin D, Rosenkrantz Hölmich L, Jakobsen LP. Metastatic basal cell carcinoma caused by carcinoma misdiagnosed as acne – case report and literature review. Clin Case Rep. 2016;4(6):601–604. https://doi.org/10.1002/ccr3.575 PMid:27398205 PMCid:PMC4891487. [PMC free article] [PubMed]
17. Lanoue J, Goldenberg G. Basal Cell Carcinoma. A Comprehensive Review of Existing and Emerging Nonsurgical Therapies. J Clin Aesthet Dermatol. 2016;9(5):26–36. PMid:27386043 PMCid:PMC4928477. [PMC free article] [PubMed]
18. Enachescu CI, Mihai MM. Clinical and histological features of basal cell carcinomas. A five-year experience in a dermatology clinic. Rev Chim. 2016;67(9):1701–1706.
19. Cohen PR. Axillary basal cell carcinoma in patients with Goltz-Gorlin syndrome:report of basal cell carcinoma in both axilla of a woman with basal cell nevus syndrome and literature review. Dermatol Online J. 2014;20(8) [PubMed]
20. Cohen PR. Basal cell carcinoma of the axilla:review of the world literature. Am J Clin Dermatol. 2014;15(2):95–100. https://doi.org/10.1007/s40257-014-0066-8 PMid:24567258. [PubMed]
21. Bajaj S, Sharma PK, Kar HK. Linear adamantinoid basal cell carcinoma in the axilla. Dermatol Online J. 2015;21(5) pii:13030/qt8k0713nb. [PubMed]
22. Mohan SV, Chang AL. Advanced Basal Cell Carcinoma:Epidemiology and Therapeutic Innovations. Curr Dermatol Rep. 2014;3:40–45. Collection 2014. [PMC free article] [PubMed]

Articles from Open Access Macedonian Journal of Medical Sciences are provided here courtesy of ID Design Press